Document title Revision of Note for guidance on minimising the risks of TSE transmission via medicinal products CPMP recommendations on vCJD and plasma derived medicinal products – CPMP recommendations on transmissible agents and urinary derived medicinal products Note for guidance on the use of bovine serum used in the manufacture of human biological medicinal products Note for guidance on the production and quality control of animal immunoglobins and immunosera for human use Cell culture inactivated influenza vaccines – Annex to Note for guidance on harmonisation of requirements for influenza vaccines EU recommendations for the influenza vaccine composition for the season 2002/ 2003 Plasma master file: